RIG
50
6
BMY
63
2
O
30
-3
DE
39
3
FSLR
47
7
ADSK
70
-4
AES
44
3
ES
29
3
URBN
55
-11
SYK
71
-2
MA
65
-2
HPE
48
-22
DNB
82
-4
GM
71
3
EXR
55
-4
XEL
67
2
LH
46
-4
M
36
5
LNC
43
-2
PCG
94
-5
RIG
50
6
BMY
63
2
O
30
-3
DE
39
3
FSLR
47
7
ADSK
70
-4
AES
44
3
ES
29
3
URBN
55
-11
SYK
71
-2
MA
65
-2
HPE
48
-22
DNB
82
-4
GM
71
3
EXR
55
-4
XEL
67
2
LH
46
-4
M
36
5
LNC
43
-2
PCG
94
-5
Financhill
Back

NYLI CBRE NextGen Real Estate ETF Vs. Dyne Therapeutics Industry Stock Comparison

Buy
57

ROOF
NYLI CBRE NextGen Real Estate ETF

Last Price:
21.05
Seasonality Move:
3.96%
Sell
46

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Buy
57
NYLI CBRE NextGen Real Estate ETF (ROOF) is a Buy

Is NYLI CBRE NextGen Real Estate ETF a Buy, Sell or Hold?

  • The current NYLI CBRE NextGen Real Estate ETF [ROOF] share price is $20.57. The Score for ROOF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • ROOF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ROOF Stock Price Chart

What is NYLI CBRE NextGen Real Estate ETF's stock price today?

  • The NYLI CBRE NextGen Real Estate ETF share price today is $20.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ROOF is experiencing selling pressure, which indicates risk of future bearish movement.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $30.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.

ROOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 35.4 Sell
Chaikin Money Flow: -197 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.88 - 21.62) Sell
Bollinger Bands (100): (20.12 - 21.96) Sell

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 47.11 Sell
Chaikin Money Flow: -1019710 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.92 - 33.44) Sell
Bollinger Bands (100): (31.39 - 42.57) Sell

ROOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.85 Sell
20-day SMA: 21.16 Sell
50-day SMA: 21.64 Sell
200-day SMA: 20.09 Buy
8-day EMA: 20.83 Sell
20-day EMA: 21.08 Sell
50-day EMA: 21.26 Sell
200-day EMA: 20.43 Buy

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.77 Buy
20-day SMA: 30.55 Sell
50-day SMA: 32.55 Sell
200-day SMA: 32.11 Sell
8-day EMA: 30.26 Buy
20-day EMA: 30.69 Sell
50-day EMA: 32.85 Sell
200-day EMA: 30.82 Sell

NYLI CBRE NextGen Real Estate ETF Earnings Growth & ROOF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.

NYLI CBRE NextGen Real Estate ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):